Skip to main content

Published locations for CAR T-cell therapy bb2121 performs well in phase 1 trial of refractory multiple myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CAR T-cell therapy bb2121 performs well in phase 1 trial of refractory multiple myeloma

User login

  • Reset your password
  • /content/car-t-cell-therapy-bb2121-performs-well-phase-1-trial-refractory-multiple-myeloma
  • /fedprac/article/199870/multiple-myeloma/car-t-cell-therapy-bb2121-performs-well-phase-1-trial
  • /hematologynews/article/199870/multiple-myeloma/car-t-cell-therapy-bb2121-performs-well-phase-1-trial
  • /oncologypractice/article/199870/multiple-myeloma/car-t-cell-therapy-bb2121-performs-well-phase-1
  • /fedprac/avaho/article/199870/multiple-myeloma/car-t-cell-therapy-bb2121-performs-well-phase-1-trial
  • /hematology-oncology/article/199870/multiple-myeloma/car-t-cell-therapy-bb2121-performs-well-phase-1